Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Buying US stocks via Gift City to get easier as Zerodha, Groww, Angel One and Upstox get nod
Buying US stocks could soon become easier for Indian retail investors after Zerodha, Groww, Angel One and Upstox secured regulatory approvals from GIFT City’s IFSCA. The licences will enable the brokerages to facilitate overseas investing, tapping into growing demand for global equities under the RBI’s Liberalised Remittance Scheme.
Urban consumption, small caps remain top bets despite monsoon concerns: Quest Investment Advisors
Rakesh Vyas, CIO and Portfolio Manager at Quest Investment Advisors, remains positive on urban consumption, saying strong retail credit growth, tax benefits and rising disposable incomes continue to support discretionary spending despite monsoon concerns. He expects select small-cap stocks to deliver 6-7% alpha through strong earnings growth and sees Eternal as a key beneficiary of improving quick-commerce profitability. Vyas has also increased exposure to mid-sized IT firms, citing attractive valuations and long-term growth prospects.
Liotech Industries IPO Day 1: Issue subscribed 8% so far. Check GMP, key details.
Liotech Industries IPO runs from June 17 to June 19, priced at ₹321 per share. Investors can apply for a minimum of 800 shares. The issue is 50% for retail and 50% for non-institutional investors, with an estimated listing price of ₹372 due to grey market premium.
Diksha Polymers IPO Day 1: GMP, subscription status, price band and other details about SME offer
Diksha Polymers IPO opened for bidding on 17 June. The fixed price is ₹112 per share, with a minimum bid of 2 lots for retail investors. The company aims to raise funds for debt repayment and corporate needs.
Wipro's Rs 15,000 crore buyback closes today: Should retail investors participate? Analysts weigh in
Wipro's Rs 15,000-crore share buyback closes on June 17, with the company set to repurchase up to 60 crore shares at Rs 250 apiece, representing 5.7% of its paid-up equity capital. Only shareholders who held Wipro shares on the June 5 record date are eligible to participate.
Leapfrog Engineering Services IPO Day 1: Issue booked 9% so far. Check GMP, key details to know
The Leapfrog Engineering Services IPO commenced on 17 June, with shares priced between ₹21-23. It has reserved 60.07% for retail investors. The company reported significant revenues and plans to utilise the funds for growth, including setting up a new assembly unit.
Riyaasat Lifestyle IPO opens tomorrow. GMP, price, other details in 10 points
The GMP of Riyaasat Lifestyle IPO is +0, according to Investorgain. Ahmedabad-based Riyaasat Lifestyle is involved in the retail sale of ethnic apparel for both men and women
JM Fin on insurance: Retail health to drive growth; Star Health top pick
The brokerage said that it prefers Star Health in the space as it has recommended a 'Buy' rating on the stock for a target price of ₹650.
GIC Shares Extend Declines As Retail OFS Opens Today
GIC Shares Drop 3% After Government Opens Offer For Sale For Retail Investors
GIC OFS opens for retail investors today. Should you participate or not? - Mint
GIC OFS opens for retail investors today. Should you participate or not?Mint
GIC shares dip 4% as Rs 3,088 crore OFS opens for retail investors. Should you participate?
General Insurance Corporation of India shares saw a dip as the government initiated an Offer for Sale. Retail investors can now bid for a stake in the insurer. The offer has already attracted strong demand from institutional investors. Market analysts suggest caution for retail investors due to profitability concerns and industry headwinds.
GIC shares dip 4% as Rs 3,088 crore OFS opens for retail investors. Should you participate?
General Insurance Corporation of India shares dropped 4% as the government's OFS opens for retail investors today at a discount. Meanwhile, Zydus Lifesciences successfully completed its cash tender offer for Assertio Holdings Inc., making it a wholly-owned subsidiary. This acquisition aims to boost Zydus's pipeline of innovative drugs.